Weighted Average Number of Shares Outstanding, Basic of SANGAMO THERAPEUTICS, INC from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
SANGAMO THERAPEUTICS, INC quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • SANGAMO THERAPEUTICS, INC Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 304,268,000, a 46% increase year-over-year.
  • SANGAMO THERAPEUTICS, INC annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 201,699,000, a 16% increase from 2023.
  • SANGAMO THERAPEUTICS, INC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 174,444,000, a 13% increase from 2022.
  • SANGAMO THERAPEUTICS, INC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 154,345,000, a 6.8% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

SANGAMO THERAPEUTICS, INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 304,268,000 +95,923,000 +46% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 256,950,000 +53,004,000 +26% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 220,269,000 +39,927,000 +22% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 201,699,000 +27,255,000 +16% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q3 2024 208,345,000 +31,174,000 +18% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 203,946,000 +29,621,000 +17% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 180,342,000 +11,809,000 +7% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 174,444,000 +20,099,000 +13% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 177,171,000 +19,129,000 +12% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 174,325,000 +26,167,000 +18% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 168,533,000 +22,315,000 +15% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 154,345,000 +9,777,000 +6.8% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 158,042,000 +12,643,000 +8.7% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 148,158,000 +4,174,000 +2.9% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 146,218,000 +3,106,000 +2.2% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 144,568,000 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
Q3 2021 145,399,000 +4,299,000 +3% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 143,984,000 +5,007,000 +3.6% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 143,112,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q3 2020 141,100,000 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 138,977,000 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2

SANGAMO THERAPEUTICS, INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 201,699,000 +27,255,000 +16% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 174,444,000 +20,099,000 +13% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 154,345,000 +9,777,000 +6.8% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 144,568,000 +10,119,000 +7.5% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024 2023 FY
2020 134,449,000 +22,335,000 +20% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 112,114,000 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.